| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC38871-25mg |
|
1356992-21-6 |
XL-784 free base - Glpbio |
0 | 需詢價 | C21H22ClF2N3O8S | |
| GC38871-10mg |
|
1356992-21-6 |
XL-784 free base - Glpbio |
0 | 需詢價 | C21H22ClF2N3O8S | |
| GC38871-5mg |
|
1356992-21-6 |
XL-784 free base - Glpbio |
0 | 需詢價 | C21H22ClF2N3O8S | |
| GC38871-1mg |
|
1356992-21-6 |
XL-784 free base - Glpbio |
0 | 需詢價 | C21H22ClF2N3O8S | |
| GC38871-10mM (in 1mL DMSO) |
|
1356992-21-6 |
XL-784 free base - Glpbio |
0 | 需詢價 | C21H22ClF2N3O8S | |
| GC38870-100mg |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38870-50mg |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38870-25mg |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38870-10mg |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38870-5mg |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38870-10mM (in 1mL DMSO) |
|
2098799-80-3 |
VH032-PEG3-acetylene - Glpbio |
0 | 需詢價 | C31H42N4O7S | |
| GC38869-10mg |
|
— |
Transdermal Peptide TFA - Glpbio |
0 | 需詢價 | C42H65F3N14O18S2 | |
| GC38869-5mg |
|
— |
Transdermal Peptide TFA - Glpbio |
0 | 需詢價 | C42H65F3N14O18S2 | |
| GC38869-1mg |
|
— |
Transdermal Peptide TFA - Glpbio |
0 | 需詢價 | C42H65F3N14O18S2 | |
| GC38868-50mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002 - Glpbio |
0 | 需詢價 | C17H17NO | |
| GC38868-25mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002 - Glpbio |
0 | 需詢價 | C17H17NO | |
| GC38868-10mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002 - Glpbio |
0 | 需詢價 | C17H17NO | |
| GC38868-5mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002 - Glpbio |
0 | 需詢價 | C17H17NO | |
| GC38867-100mg |
|
217817-01-1 |
Tos-PEG4-t-butyl ester - Glpbio |
0 | 需詢價 | C20H32O8S | |
| GC38867-50mg |
|
217817-01-1 |
Tos-PEG4-t-butyl ester - Glpbio |
0 | 需詢價 | C20H32O8S | |
小泰
|
010-60710855
|